H2020Индивидуална стипендия2018–2021

Smart BioSense · Smart engineered Bioreceptors for developing BioSensors

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2018-11-01 → 2021-10-31
Финансиране от ЕС
244 269 €
Участници
2
Схема
MSCA-IF-GF

Линиите свързват координатора с партньорите.

Накратко на български

Биорецепторите се модифицират, за да разпознават по-точно малки промени в концентрацията на веществата чрез механизми като кооперативност. Подобрените свойства на тези рецептори повишават прецизността на измерванията при различни видове биосензори.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Smart engineered Bioreceptors for developing BioSensors

Although the impressive advances in the field of biosensing, most efforts are still oriented to deliver lower limits of detection by updating or improving either the molecular reporters or the reading set ups, while little effort is addressed towards the recognition element/bio receptor. Better insight in the recognition element biophysics allow to tune its properties to match the needs for the receptor in each particular context. These improvements in receptors’ properties have a direct impact and benefit on any biosensing assay technology assay, not only the new developed, but also in previously established techniques. The action was divided into three main objectives: 1. Exploration and optimization of binding conformational changes as a signal transduction mechanism. 2. Rational introduction of cooperativity to improve measurement precision. 3. Demonstration of the application of these mechanism in representative biosensors. In the MSCA action, the experienced researcher (Dr. Alejandro Chamorro Garcia) spent the outgoing phase in the host institution (University of California Santa Barbara, UCSB) in Prof. Kevin Plaxco research lab. The work carried out during outgoing phase the work had been centered in the use of diverse mechanisms, such as cooperativity and sequestration, to tune biological receptors’ recognition properties towards the application of the improved receptors in biosensing assays. With the final goal to achieve improved response from the sensing assays in which are applied, we focused on narrowing the dynamic range to obtain more precise reads of subtle changes in concentrations, in an on/off fashion. In the incoming phase the experience researched joined Prof. Francesco Ricci lab (University of Rome Tor Vergata) to further pursue the study of mechanisms to tune binding properties of bioreceptors and its applications in the development of biosensors. In conclusion, during the action, the experience researcher had received training in electrochemical aptamer-based biosensors (EAB sensors) and biophysics of biological receptors. The knowledge acquired has been put into practice by studying the effect of the position of the label in the aptamer in EAB sensors and developing an EAB sensor for the detection of a chemotherapeutical drug: methotrexate. In another line, the experienced researcher applyed a previously described principle (sequestration) to tune receptors’ binding properties with the aim to improve the dose response parameters. That means inducing bigger transitions of signal over target concentration, achieving this way, better sensitivity over subtle variations in concentration. The principles developed and studies have been tested in few example testing scenarios, with the potential to be exploited in other contexts and help other researchers to incorporate improvements in their sensing systems.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

WHY: Although the impressive advances in the field of biosensing, most efforts are oriented in delivering lower limits of detection, whereas other aspects remain unattended. As consequence, the majority of novel assays for the detection of biomarkers still require: sophisticated equipment, washing intensive, reagent-intensive multi step processes. To effectively overcome the cited limitations and clear the way to the desired point-of-care tests (reagentless, single step, quick response, reusable, user friendly, robust and precise) it is mandatory to engineer the recognition elements (RE).WHAT: The aim of the proposal, SBS, is to develop novel electrochemical biosensors by engineering the RE responsible of detection. I will achieve so by rationally applying mechanisms found in nature; First, I will explore the amazing single-step, reagentless signal transduction naturally occurring biological systems. Next, I will enhance precision of the recognition element (high output upon subtle variations of target concentration) through the insertion of cooperativity. Finally, I will deploy the engineered RE in biosensing approaches.HOW: During the fellowship I will undertake a training program to develop skills and acquire expertise in biophysiscs, molecular biology and electrochemical biosensor. In a first out-going phase I will join Prof. K. Plaxco (UCSB) who is a world-wide expert in biomolecule folding and biophysics, there I will develop the engineered folding based RE. In the subsequent phase I will join Prof. F. Ricci group at University of Rome, Tor Vergata. Prof. Ricci leads a young and dynamic group specialized in the field nanotechnology, DNA engineering and electrochemical biosensors. Within his group I will work in the application of the RE into biosensors. The fellowship will grant the chance to build a robust, prestigious and attractive scientific record, while the knowledge and skills acquired will improve gratly my career.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз